Steady-state B-type natriuretic peptide levels in patients with atrial fibrillation of various clinical backgrounds

Heart and Vessels

Volumn 27, Issue 3, 2012, Pages 280-286

  Sadanaga, Tsuneaki ^a   Mitamura, Hideo ^b   Kohsaka, Shun ^c   Ogawa, Satoshi ^d  

^a Ueki Hospital   (Japan)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d International University of Health and Welfare Mita Hospital   (Japan)

Author keywords

Atrial fibrillation; B type natriuretic peptide; Heart failure; Structural heart disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEADY STATE; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; ROC CURVE; UP-REGULATION; YOUNG ADULT;

EID: 84862906651     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-011-0151-3     Document Type: Article

References (20)

1. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings. Circulation 105: 595-601
2. Lukowicz T, Fischera M, Hense HW, Dfring A, Stritzked J, Rieggera G, Schunkert H, Luchner A (2005) BNP as a marker of diastolic dysfunction in the general population: importance of left ventricular hypertrophy. Eur J Heart Fail 7: 525-531
3. Seki S, Tsurusaki T, Kasai T, Taniguchi I,Mochizuki S, Yoshimura M (2008) Clinical significance of B-type natriuretic peptide in the assessment of untreated hypertension. Circ J 72: 770-777
4. Silvet H, Young-Xu Y, Walleigh D, Ravid S (2003) Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 92: 1124-1127
5. Kim BJ, Hwang SJ, Sung KC, Kim BS, Kang JH, Lee MH, Park JR (2007) Assessment of factors affecting plasma BNP levels in patients with chronic atrial fibrillation and preserved left ventricular systolic function. Int J Cardiol 118: 145-150
6. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Breathing Not Properly Multinational Study Investigators (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161-167
7. Knudsen CW, Omland T, Clopton P, Westheim A, Wu AH, Duc P, McCord J, Nowak RM, Hollander JE, Storrow AB, Abraham WT, McCullough PA, Maisel A (2005) Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol 46: 838-844
8. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470
10. Gwechenberger M, Huelsmann M, Graf S, Berger R, Bonderman D, Stanek B, Rauscha F, Pacher R (2004) Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers. Eur J Clin Invest 34: 811-817
11. Rossi A, Enriquez-Sarano M, Burnett JC Jr, Lerman A, Abel MD, Seward JB (2000) Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 35: 1256-1262
12. Doust J, Lehman R, Glasziou P (2006) The role of BNP testing in heart failure. Am Fam Physician 74: 1893-1898
13. Tsuchida K, Tanabe K (2004) Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion. J Cardiol44: 1-11
14. Jourdain P, Bellorini M, Funck F, Fulla Y, Guillard N, Loiret J, Thebault B, Sadeg N, Desnos M (2002) Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study. Eur J Heart Fail 4: 263-267
15. Li J, Wang L (2006) B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart Vessels 21: 137-140
16. Bakowski D, Wozakowska-Kaplon B, Opolski G (2009) The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation. Pacing Clin Electrophysiol 32: 745-752
17. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348: 2007-2018
18. Engelmann MD, Niemann L, Kanstrup IL, Skagen K, Godtfredsen J (2005) Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation. Int J Cardiol 105: 31-39
19. Wu AH, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, McGill C, Katten D, Heller G (2003) Biological variation for N-terminal pro-and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92: 628-631
20. Vogeser M, Jacob K (2001) B-type natriuretic peptide (BNP)-validation of an immediate response assay. Clin Lab 47: 29-33